Akero Therapeutics, Inc.

South San Francisco, United States akerotx.com

Overview

Akero Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing treatments for serious metabolic diseases with high unmet medical needs. The company focuses on advancing its pipeline of innovative therapies designed to treat nonalcoholic steatohepatitis (NASH) and potentially other metabolic diseases.

Therapeutic areas

Metabolic DiseasesLiver Diseases

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Akero Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

89bio, Inc.
United States
Celerion, Inc.
United States
Charles River Laboratories International, Inc.
United States
Durect Corporation
USA
Esperion Therapeutics, Inc.
United States
Gastro Innovations Incorporated
USA
Gastroenterology Research Foundation
United States
Gilead Sciences, Inc.
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo